Purkiss Capital Advisors LLC lowered its holdings in shares of The Allstate Corporation (NYSE:ALL – Free Report) by 6.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,359 shares of the insurance provider’s stock after selling 100 shares during the period. Purkiss Capital Advisors LLC’s holdings in Allstate were worth $274,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Arlington Trust Co LLC boosted its stake in shares of Allstate by 261.8% during the second quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider’s stock worth $25,000 after buying an additional 89 shares during the period. Hughes Financial Services LLC purchased a new stake in Allstate during the 1st quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd lifted its position in Allstate by 315.0% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 166 shares of the insurance provider’s stock worth $33,000 after acquiring an additional 126 shares during the period. Hilltop National Bank purchased a new position in shares of Allstate in the 2nd quarter valued at approximately $34,000. Finally, Chilton Capital Management LLC acquired a new position in shares of Allstate in the second quarter valued at approximately $38,000. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Allstate Stock Performance
NYSE ALL opened at $192.99 on Tuesday. The business has a 50 day moving average price of $203.99 and a 200 day moving average price of $201.13. The company has a market capitalization of $50.85 billion, a P/E ratio of 9.07, a PEG ratio of 0.70 and a beta of 0.38. The Allstate Corporation has a 1-year low of $176.00 and a 1-year high of $215.70. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.43 and a quick ratio of 0.43.
Analysts Set New Price Targets
ALL has been the topic of several analyst reports. Evercore ISI set a $233.00 target price on shares of Allstate and gave the company an “in-line” rating in a report on Wednesday, October 1st. Wolfe Research raised Allstate to a “strong-buy” rating in a report on Tuesday, September 16th. Jefferies Financial Group increased their target price on Allstate from $254.00 to $255.00 and gave the stock a “buy” rating in a research note on Monday, August 11th. Cantor Fitzgerald upgraded Allstate to a “hold” rating in a research note on Wednesday, August 13th. Finally, Morgan Stanley upped their price objective on Allstate from $235.00 to $245.00 and gave the stock an “overweight” rating in a report on Friday, August 1st. Two analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Allstate currently has an average rating of “Moderate Buy” and a consensus target price of $234.27.
Check Out Our Latest Stock Analysis on Allstate
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- Canada Bond Market Holiday: How to Invest and Trade
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- Following Congress Stock Trades
- Does the Trump-Induced Quantum Stock Rally Have Legs?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
